Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genome-Wide Identification of the PME Gene Family in Plum and Its Potential Roles in Fruit Texture Formation.

Genes·2026
Same author

<i>PsAAT3</i> Drives Ester Accumulation and Fruity Aroma Formation During Ripening in Chinese Plum (<i>Prunus salicina</i>) Through Integrated Volatile Profiling and Transcriptomics.

Plants (Basel, Switzerland)·2026
Same author

Pan-cancer analysis identifies FAM111B as a biomarker for immune suppression microenvironment in low-grade gliomas.

Translational cancer research·2026
Same author

Activation of SV2B Inhibits Matrix-Stiffness-Induced Tumorigenesis and EMT in Glioma via FAK/PI3K/AKT Signaling Pathway.

Oncology and therapy·2025
Same author

Targeting endothelial cells: the pathological mechanisms and therapeutic innovations in pulmonary arterial hypertension.

Frontiers in cell and developmental biology·2025
Same author

Phylloquinone Attenuates Oxygen-Glucose Deprivation-induced Neuronal Injury by Inhibiting Ferroptosis via the xCT/GPX4 Pathway.

Neurochemical research·2025

Related Experiment Video

Updated: Aug 5, 2025

Injection of Hydrogel Biomaterial Scaffolds to The Brain After Stroke
09:41

Injection of Hydrogel Biomaterial Scaffolds to The Brain After Stroke

Published on: October 1, 2020

5.2K

Biomimetic nanoparticles in ischemic stroke therapy.

Zihao Liu1, Qian Xia2, Dengzhen Ma1

  • 1Department of Neurosurgery, Shandong Provincial Hospital, Shandong University, Jinan, 250021 China.

Discover Nano
|March 27, 2023
PubMed
Summary
This summary is machine-generated.

Biomimetic nanoparticles, using cell membranes, offer a promising approach for ischemic stroke therapy by improving drug delivery. This method enhances circulation time and targeting, overcoming limitations of current treatments.

Keywords:
Biomimetic nanoparticlesDrug delivery systemIschemic strokeMembrane camouflage

More Related Videos

Implantation of Miniosmotic Pumps and Delivery of Tract Tracers to Study Brain Reorganization in Pathophysiological Conditions
10:32

Implantation of Miniosmotic Pumps and Delivery of Tract Tracers to Study Brain Reorganization in Pathophysiological Conditions

Published on: January 18, 2016

14.3K
A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice
06:54

A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice

Published on: June 22, 2022

2.8K

Related Experiment Videos

Last Updated: Aug 5, 2025

Injection of Hydrogel Biomaterial Scaffolds to The Brain After Stroke
09:41

Injection of Hydrogel Biomaterial Scaffolds to The Brain After Stroke

Published on: October 1, 2020

5.2K
Implantation of Miniosmotic Pumps and Delivery of Tract Tracers to Study Brain Reorganization in Pathophysiological Conditions
10:32

Implantation of Miniosmotic Pumps and Delivery of Tract Tracers to Study Brain Reorganization in Pathophysiological Conditions

Published on: January 18, 2016

14.3K
A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice
06:54

A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice

Published on: June 22, 2022

2.8K

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Neuroscience

Background:

  • Ischemic stroke presents significant therapeutic challenges due to limited treatment options.
  • Nanoparticle drug delivery systems are emerging as a key strategy for treating neurological disorders.
  • Biomimetic nanoparticles, combining natural membranes with synthetic cores, offer enhanced biocompatibility and efficacy.

Purpose of the Study:

  • To review the advancements in biomimetic nanoparticle drug delivery systems for ischemic stroke.
  • To highlight the advantages of biomimetic camouflage in improving nanoparticle performance.
  • To discuss the potential of these novel systems in future stroke therapies.

Main Methods:

  • Review of literature on membrane-derived nanoparticles for drug delivery.
  • Analysis of biomimetic strategies for enhancing nanoparticle circulation and targeting.
  • Exemplification of membrane-based nanoparticles from various donor cells.

Main Results:

  • Biomimetic nanoparticles inherit intrinsic nanoparticle properties while gaining biological functions from source cells.
  • Membrane camouflage effectively prolongs circulation, reduces immunogenicity, and improves targeting compared to conventional methods.
  • This approach is more convenient and biocompatible than traditional surface modification techniques.

Conclusions:

  • Biomimetic nanoparticles represent a significant advancement in drug delivery for ischemic stroke.
  • Their ability to mimic natural cell membranes offers superior pharmacokinetic and pharmacodynamic profiles.
  • Further research into biomimetic nanoparticles holds great promise for developing effective ischemic stroke therapies.